[go: up one dir, main page]

GB2053900A - 6,8-Dibromo-1,4-dihydro-2H- 3,1-benzoxazine-2-one and the production of bromhexin - Google Patents

6,8-Dibromo-1,4-dihydro-2H- 3,1-benzoxazine-2-one and the production of bromhexin Download PDF

Info

Publication number
GB2053900A
GB2053900A GB8017619A GB8017619A GB2053900A GB 2053900 A GB2053900 A GB 2053900A GB 8017619 A GB8017619 A GB 8017619A GB 8017619 A GB8017619 A GB 8017619A GB 2053900 A GB2053900 A GB 2053900A
Authority
GB
United Kingdom
Prior art keywords
dihydro
bromhexin
dibromo
benzoxazin
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8017619A
Other versions
GB2053900B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AS
Original Assignee
Gea AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK230179A external-priority patent/DK145718C/en
Priority claimed from DK230079A external-priority patent/DK145714C/en
Application filed by Gea AS filed Critical Gea AS
Publication of GB2053900A publication Critical patent/GB2053900A/en
Application granted granted Critical
Publication of GB2053900B publication Critical patent/GB2053900B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

N-(2-amino-3,5-dibromobenzyl)- N-methyl-cyclohexylamine, the hydrochloride of which has the formula <IMAGE> is prepared by brominating 1,4- dihydro-2H-3,1-benzoxazin-2-one with free bromine to form the hitherto unknown intermediate 6,8-dibromo- 1,4-dihydro-2H-3,1-benzoxazin-2- one, and reacting this with N-methyl- cyclohexylamine to bromhexin. Preferably, the reaction takes place by heating in N-monomethylformamide to the boiling point of the latter.

Description

SPECIFICATION Process for the production of bromhexin The invention relates to a novel process for the production of bromhexin, a non-proprietory name for N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexylamine, which is a known compound having a mucolytic and cough-relieving effect, and to an intermediate for use in the process.
Different methods of producing bromhexin are known and described in the Danish Patents Nos.
101,066,101,301, 101 795, and 119,408, in the Danish published patent specifications Nos.
135,499,135,574, and 135,680, and DE-OS 2,273,193.
These known methods have disadvantages either in the form of needing temporary protective measures for non-reacting substituents or in difficultly accessible starting materials or costly reduction agents, and common to all of them is that the disadvantages result in reduced yields.
The object of the invention is to provide a process for the production of bromhexin, in which the said disadvantages are avoided, and the bromhexin is recovered in a high yield and extremely pure.
In the process of the invention, 1 ,4-dihydro-2H-3,1 -benzoxazin-2-one is reacted with free bromine to give 6,8-dibromo-1 ,4-dihydro-2H-3,1 -benzoxazin-2-one, which is then reacted with N-methylcyclohexylamine to form bromhexin, the latter being recovered as an acid addition salt from the reaction mixture.
The reactions take place according to the following scheme of reactions:
The starting material I is a known compound, which can be prepared from o-aminobenzyl alcohol by condensation with for example phosgene.
The hitherto unknown intermediate II is a white, crystalline compound being slightly soluble in water and melting at 21 8-2200C.
In a preferred embodiment of the process, the reaction with N-methylhexylamine according to the invention takes place in solution in N-monomethylformamide, since hereby a yield of up to-90% is obtained by the reaction.
The process of the invention is illustrated by the following Examples.
EXAMPLE 1 To a solution of 9.0 g (0.0604 mole) of 1 ,4-dihydro-2H-3,1-benzoxazin-2-one in 40 ml of glacial acetic acid were added 60.9 g (0.38 mole) of bromine, whereby the temperature increased from 240 to 740 C. The reaction mixture was left to cool to room temperature and was then poured into 500 ml of water, whereby a precipitation of the brominated benzoxazinone took place. The precipitate was filtered off and washed on the filter, first with water, then with a weak solution of sodium hydrogen sulphite and finally with hexane.
The excess bromine could be recovered from the parent lye and washwater by distillation.
The yield of the brominated benzoxazinone was 16.5 g (0.0537 mole), corresponding to 89% of the theoretical yield. The melting point was 21 8-2200C, and thin layer chromatography showed no impurities.
A mixture of 3.07 g (0.010 mole) of the recovered 6,8-dibromo-1 ,4-dihydro-2H-3,1 -benzoxazin2-one and 4.52 g (0.040 mole) of N-methyl-cyclohexylamine in 10 ml of N-monomethylformamide was heated with stirring and refluxing for 2 hours on a 210"C hot oil bath. After cooling, the mixture was poured into 70 ml of water, and concentrated hydrochloric acid was added until acid reaction.
By cooling in ice-water with stirring, N-(2-amino-3,5-dibromobenzyl)-N-methyl cyclohexylammonium chloride (bromhexin hydrochloride) crystallized and was filtered off after one hour, washed with water, and dried. The yield was 3.7 g (8.97 millimoles), corresponding to 89.7% of the theoretical yield. The melting point was 232-233.50C, and the compound was analytically pure.
EXAMPLE 2 A mixture of 1.65 g (5.4 millimoles) of the 6,8-dibromo-1 ,4-dihydro-2H-3,1 -benzoxazin-2-one of Example 1 and 2.4 g (21 millimoles) of N-methyl-cyclohexylamine in 10 ml of diethyleneglycol was heated for 20 hours with stirring and refluxing on a 21 00C hot oil bath. After cooling, 150 ml of water were added, and then hydrochloric acid was added until acid reaction, after which the mixture was heated to reflux temperature. To the boiling mixture were added 10 ml of ethanol and active carbon, after which clear filtration at reflux temperature was carried out.
The filtrate was cooled in ice-water, whereby N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexylammonium chloride crystallized. The compound was filtered off and washed with water. The yield of the analytically pure compound was 1.1 g (2.67 millimoles), corresponding to 49.4% of the theoretical yield.

Claims (4)

1. Process for the production of bromhexin, in which 1,4-dihydro-2H-3,1 -benzoxazin-2-one is reacted with free bromine to form 6,8-dibromo-l ,4-dihydro-2H-3.1 -benzoxazin-2-one, which is then reacted with N-methyl-cyclohexylamine to form bromhexin, which is recovered from the reaction mixture as an acid addition salt.
2. The process of claim 1, in which the reaction with N-methyl-cyclohexylamine takes place in solution in N-monomethylformamide.
3. 6,8-Dibromo- 1 ,4-dihydro-2H-3, 1 -benzoxazin-2-one.
4. Process for the production of bromhexin, substantially as herein described in Example 1 or Example 2.
GB8017619A 1979-06-01 1980-05-29 6,8-dibromo-1,4-dihydro-2h-3,1-benzoxazine-2-one and the production of bromhexin Expired GB2053900B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK230179A DK145718C (en) 1979-06-01 1979-06-01 DIBROME COMPOUND USE AS INTERMEDIATE IN THE PREPARATION OF N- (2-AMINO-3,5-DIBROMBENZYL) -N-METYLCYCLOHEXYLAMINE
DK230079A DK145714C (en) 1979-06-01 1979-06-01 METHOD FOR PREPARING N- (2-AMINO-3,5-DIBROMBENZYL) -N-METYLYCYLOHEXYLAMINE

Publications (2)

Publication Number Publication Date
GB2053900A true GB2053900A (en) 1981-02-11
GB2053900B GB2053900B (en) 1983-04-20

Family

ID=26066477

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8017619A Expired GB2053900B (en) 1979-06-01 1980-05-29 6,8-dibromo-1,4-dihydro-2h-3,1-benzoxazine-2-one and the production of bromhexin

Country Status (11)

Country Link
AT (1) AT371800B (en)
CH (1) CH642617A5 (en)
DE (1) DE3020604A1 (en)
ES (1) ES492005A0 (en)
FI (1) FI68808C (en)
GB (1) GB2053900B (en)
IE (1) IE49820B1 (en)
KE (1) KE3302A (en)
NL (1) NL8003153A (en)
NO (2) NO148372C (en)
SE (1) SE433847B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775316A (en) * 2012-08-17 2012-11-14 夏智红 Bromhexine hydrochloride compound and medicine composition thereof
CN102924295A (en) * 2012-10-09 2013-02-13 石家庄东方药业有限公司 Bromhexine hydrochloride crystal as well as preparation method and application of crystal
CN103145564A (en) * 2013-03-15 2013-06-12 湖北美林药业有限公司 Bromhexine hydrochloride compound and pharmaceutical composition thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881955B1 (en) 2005-02-11 2007-05-11 Oreal COSMETIC NANOEMULSION CONTAINING HYDROXYL UREA COMPOUND

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775316A (en) * 2012-08-17 2012-11-14 夏智红 Bromhexine hydrochloride compound and medicine composition thereof
CN102775316B (en) * 2012-08-17 2013-06-12 夏智红 Bromhexine hydrochloride compound and medicine composition thereof
CN102924295A (en) * 2012-10-09 2013-02-13 石家庄东方药业有限公司 Bromhexine hydrochloride crystal as well as preparation method and application of crystal
CN102924295B (en) * 2012-10-09 2014-10-29 石家庄东方药业有限公司 Bromhexine hydrochloride crystal as well as preparation method and application of crystal
CN103145564A (en) * 2013-03-15 2013-06-12 湖北美林药业有限公司 Bromhexine hydrochloride compound and pharmaceutical composition thereof
CN103145564B (en) * 2013-03-15 2014-06-18 湖北美林药业有限公司 Bromhexine hydrochloride compound and pharmaceutical composition thereof

Also Published As

Publication number Publication date
CH642617A5 (en) 1984-04-30
NO823977L (en) 1980-12-02
SE8003874L (en) 1980-12-02
NL8003153A (en) 1980-12-03
FI801705A (en) 1980-12-02
NO148415B (en) 1983-06-27
AT371800B (en) 1983-07-25
FI68808B (en) 1985-07-31
KE3302A (en) 1983-08-19
ATA288580A (en) 1982-12-15
GB2053900B (en) 1983-04-20
ES8104185A1 (en) 1981-04-01
FI68808C (en) 1985-11-11
ES492005A0 (en) 1981-04-01
NO801617L (en) 1980-12-02
SE433847B (en) 1984-06-18
NO148415C (en) 1983-10-12
IE49820B1 (en) 1985-12-25
DE3020604A1 (en) 1980-12-11
NO148372B (en) 1983-06-20
IE801081L (en) 1980-12-01
NO148372C (en) 1983-09-28

Similar Documents

Publication Publication Date Title
JP3228516B2 (en) Naphthol derivatives and their production
CA1310017C (en) Process for the preparation of 2, 6-dichlorodiphenylamino-acetic acid derivatives
KR940008916B1 (en) Method for preparing alkyl ester of tetrachloro-2-cyanobenzoic acid
GB2053900A (en) 6,8-Dibromo-1,4-dihydro-2H- 3,1-benzoxazine-2-one and the production of bromhexin
WO2022121853A1 (en) Method for preparing 2-hydroxy-5-[2-(4-(trifluoromethylphenyl)ethylamino)]benzoic acid
KR100235808B1 (en) Method of preparing keto acid
Ishikawa et al. Reactions of perfluoro-2-methyl-2-pentene and octafluoroisobutylene with arylamines.
US2574150A (en) Acenaphthenyl amino alcohols
JPS63165331A (en) Orthocyanogenation of phenols or phenylamines
US3655664A (en) 2-aryl-4(3h)-quinazolinones
JPH04169583A (en) Phenothiazine derivative and its production
TW201206950A (en) Method for producing N-substituted-2-amino-4-(hydroxymethylphosphinyl)-2- butenoic acid
US3083233A (en) Chloeomethylation process
US4235819A (en) Process for isolating 1-(alkoxyphenyl)-5-(phenyl)biguanide compounds from a crude, acid reaction mixture thereof
US4960955A (en) Process for making 4-chloro-2-methyl-5-nitro-phenol
JPH0150219B2 (en)
KR0174333B1 (en) Process for preparing fluoran dye
KR960005518B1 (en) Preparation of 1-amino-4-[[2- (substitutedamino) methyl-4-methyl-6-sulfophenyl] amino] -9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid
RU1031103C (en) Method of obtaining 9, 10-bis-(phenylethyl)-anthracene and its chlor derivatives
KR920001768B1 (en) Process for preparing cromone carboxylate
KR810001695B1 (en) Process for the preparation of terephthalamide derivatives
JPS603062B2 (en) Method for producing 8-hydroxycarbostyryl derivative
KR100516383B1 (en) New manufacturing process of dihydrocarbostyril derivatives
JPH0611718B2 (en) Method for producing aromatic fluorine compound
GB2104508A (en) Improved process for the preparation of 2,4,-diamino-5-(3&#39;,4&#39;,5&#39;-trimethoxy-benzyl) pyrimidine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee